A recent study of Psilocybin—the main ingredient in magic mushrooms—has shown promise for those who do not respond to oral anti-depressants.
Desperate times call for desperate measures.
New depression medication could be on the horizon as researchers pinpoint location of brain responsible for regulating depression
[DIGEST: Scientific American, Lancet Psychiatry, Huffington Post] The first clinical trial to use psilocybin, the active compound in “magic mushrooms,” to treat major depression shows promise in a small but breakthrough study. Researchers from Imperial College London gave psilocybin to 12 people suffering from severe depression. One week after receiving an oral dose of the … Continued
Some severely depressed patients are seeking ketamine treatment for instant relief of severe symptoms, but the effects of long-term use of the treatment are unknown.